Clinical trial

Clinical Study of Compound Ciwujia Granules in the Treatment of Depression

NCT07085143

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Compound Ciwujia Granules Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Study of Compound Ciwujia Granules in the Treatment of Depression

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhasePHASE4

Conditions

Depression - Major Depressive Disorderunresolved

Depression Disordersunresolved

Interventions

Compound Ciwujia GranulesDRUG

placeboDRUG

Sponsors & collaborators

Shanghai Mental Health Centerlead sponsor

Heilongjiang Quanle Pharmaceutical Co., Ltd.collaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07085143 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.